On November 17, 2025, NHS England published a draft 2026/27 NHS Payment Scheme (NHSPS) and launched a consultation. While the overall payment model remains, some specific changes are proposed, including new blended payments for urgent and emergency care, radiotherapy, and genomic testing, as well as two new Best Practice Tariffs (BPT) to incentivize day case procedures, and 10 Year Health Plan referral-to-treatment (RTT) priorities. The deadline for comment submission is December 16, 2025.

MTRC, a leading boutique Med Tech market access consultancy in Europe, is looking for a Director of Market Access and HEOR.

In October 2025, Health Technology Wales (HTW) accomplished two full appraisals on digital interventions for chronic kidney disease and at-home video monitoring for the diagnosis and management of epilepsy. Additionally, six Med Tech-related Topic Exploration Reports were published in the IVD, e-health, gastrointestinal, and endoscopy fields.

MTRC is seeking a Junior Research Fellow to contribute to our evidence synthesis projects, including systematic reviews and value dossiers, in the evolving field of medical devices. Work is purely analytical, no hands-on/clinical/lab work is involved.

MTRC is looking for an experienced Health Economist to work on international health economic projects in the field of medical devices.

MTRC is looking for a Senior Health Economist to work on international health economic projects in the field of medical devices.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. In a recent publication, Johns et al. examined the practical implications of the EU Joint Clinical Assessment (JCA) for countries considering cost-effectiveness analyses.

Since March 2025, the Dutch Healthcare Institute (ZIN) has been establishing new standards for vascular surgery and cancer treatment, resulting in the centralization of complex interventions only in hospitals that consistently demonstrate a high volume of such procedures. In November 2025, the seven regions agreed on which hospitals would provide complex cancer and vascular procedures starting in 2026, with a one-year transition period before the new care distribution began on January 1, 2027.

MTRC announces the launch of its free Market Access Training Program, supporting professionals new to the European MedTech landscape. The first cohort begins on 15 January 2026, featuring an integrated curriculum of webinars, recorded sessions, and expert-guided practical application.

In October 2025, the Belgian National Institute for Health and Disability Insurance (INAMI/RIZIV) updated the List of implants and invasive medical devices. A new sub-chapter with multiple material codes for the reconstruction of large bone defects and a new sub-chapter with a material code for a pre-formed periarticular osteosynthesis plate were introduced. Two new Nominative lists for brand-specific devices for the reconstruction of large bone defects were also published.

On November 4, 2025, NHS England published the strategic commissioning framework to support the 10 Year Health Plan ambitions. The document outlines that strategic commissioning will be the key role of integrated care boards (ICBs) in the future. It is expected that all ICBs will begin to adopt this approach as part of the NHS planning process for the financial year 2026/27.

MTRC invites market access professionals from MedTech, IVD, and digital health companies to participate in a short online survey exploring how industry experts stay informed about developments in market access.